The effects of vitamin D3 supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: A randomized double blind placebo controlled clinical trial
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 13 (1) , 278-283
Abstract
No abstract availableKeywords
Funding Information
- Tabriz University of Medical Sciences
This publication has 34 references indexed in Scilit:
- Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in IranJournal of Diabetes & Metabolic Disorders, 2014
- The effect of vitamin D on insulin resistance in patients with type 2 diabetesDiabetology & Metabolic Syndrome, 2013
- Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3Laboratory Investigation, 2012
- Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rateKidney International, 2011
- The Association of Vitamin D Deficiency and Insufficiency with Diabetic Nephropathy: Implications for Health DisparitiesThe Journal of the American Board of Family Medicine, 2009
- Microvascular and Macrovascular Complications of DiabetesClinical Diabetes, 2008
- Inflammatory Cells in Renal Injury and RepairSeminars in Nephrology, 2007
- Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell lineJournal of Neuroscience Research, 2002
- Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis StudyKidney International, 2000
- Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathyKidney International, 1991